The Ongoing Opioid Crisis: How a National Tragedy and Hollywood Awareness Made New Law, Created Treatment Resources, and Deepened the Need for Collaborative Care

Linda is Barclay Damon’s Health Care Controversies Team leader. A nationally recognized litigator and health care lawyer with over 30 years of experience, she serves as lead counsel as well as national, regional, and local counsel in regulatory and compliance matters and the prosecution and defense of claims brought in state and federal courts on behalf of large groups of businesses and institutional clients in various settings and venues. Linda is a trusted advisor to health care providers, pharmaceutical companies, and pharmacies nationwide in resolving high-stakes disputes and government investigations and regulatory proceedings. She represents health care professionals and entities in all types of civil, criminal, and administrative proceedings, hearings, and appeals before various federal and state regulatory agencies, including the NYS Office of the Medicaid Inspector General (OMIG), the NYS Attorney General’s Office (OAG), the NYS Department of Health (DOH), and their federal counterparts, including the Office of Inspector General (OIG) and the United States Department of Justice (DOJ), among others. In addition to her role at Barclay Damon, for over 20 years, Linda served as court-appointed defense liaison counsel for three jurisdictions in New York State in asbestos litigation, working with hundreds of defense firms and the judiciary in the administration of these cases. She currently serves as a court appointee to several high-profile administrative committees for the New York State and federal court systems. Linda also serves as a judicial hearing officer, hearing cases involving alleged judicial misconduct by the judiciary.

Brad is co-leader of Barclay Damon’s Health Care Controversies Team. He concentrates his national practice on providing legal services to clients in the pharmaceutical industry, including independent retail, chain, specialty, infusion and compounding pharmacies, as well as health care systems. Brad also represents wholesalers, manufacturers, technology companies, and others with legal, regulatory, and compliance issues in the pharmacy space. He represents other health care providers, including physicians, laboratories, and durable medical equipment (DME) providers, with issues relating to network participation and reimbursement issues. Brad counsels clients nationwide on issues with health plans, pharmacy benefit managers (PBMs), and government entities, such as credentialing and enrollment, audits and investigations, network terminations, and reimbursement disputes. Specifically, Brad has assisted providers in overturning enrollment denials and with the recovery of millions of dollars for providers following challenges to audit findings or improper reimbursements. Brad also counsels clients in matters pertaining to contract management, best practices, and other business-related issues, with a focus on those entities operating in the pharmaceutical industry. For example, Brad assists clients in understanding and evaluating risks with data privacy and security, marketing and payment models, and interplay with other agreements entered by the client. Brad represents entities in pharmacy- and other health care- related transactions, including those involving private and chain sales or private equity. Brad also assists entities with corporate.